Genetic variation in the FMO and GSTO gene clusters impacts arsenic metabolism in humans
PLOS Genetics · 2025
DOI: 10.1371/journal.pgen.1011826 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Genetics, 2025. Verfasst von Lizeth I Tamayo und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Public Health Sciences, University of Chicago, Chicago, Illinois, United States of America. Hauptthemen laut MEDLINE: Arsenic, Oxygenases, Glutathione Transferase. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIEHS NIH HHS, NIDDK NIH HHS, National Institute of Environmental Health Sciences.
Abstract (Originalsprache)
Background
In Bangladesh, > 50 million individuals are chronically exposed to inorganic arsenic (iAs) through drinking water, increasing risk for cancer and other iAs-related diseases. Previous studies show that individuals’ ability to metabolize and eliminate iAs, and their risk of toxicity, is influenced by genetic variation in the AS3MT and FTCD gene regions.
Methods
To identify additional loci influencing arsenic metabolism, we used data from Bangladeshi individuals to conduct genome-wide association analyses of the relative abundances of arsenic species measured in both urine (n = 6,540) and blood (n = 976). These species include iAs, monomethylated arsenic (MMA) and dimethylated arsenic (DMA) species.
Results
In analyses of urine arsenic species, we identified a novel association signal in the FMO gene cluster (1q24.3), with the lead SNP residing in FMO3 (MMA% P = 4.2x10 -16 ). In analyses of blood arsenic species, we identified an additional signal in the FMO cluster, with the lead SNP residing in FMO4 (DMA% P = 2.3x10 -22 ) and a novel signal at 10q25.1, with the lead SNP in GSTO1 (DMA% P = 5.3x10 -13 ). Lead SNPs at FMO3 and GSTO1 are associated with the splicing of FMO3 and GSTO1 , respectively, in multiple tissue types, but also contain missense variants. The lead SNPs at FMO4 are associated with FMO4 expression level in multiple tissue types. These newly identified SNPs did not show a clear association with risk for arsenic-induced skin lesions (P > 0.05), based on 3,448 cases and 5,207 controls.
Conclusion
We identified novel loci influencing arsenic metabolites measured in both urine and blood. FMOs are involved in the oxidation of xenobiotics but have no known direct role in arsenic metabolism, while GSTO1 has a well-established role in catalyzing the reduction of arsenic species. The novel associations we report appear specific to blood or urine, with no detectable impact on skin toxicity risk, pointing to complexities in arsenic metabolism and its genetic contributors that require further study.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Public Health Sciences, University of Chicago, Chicago, Illinois, United States of America.
- Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, Canada.
- Department of Pathology, University of Illinois Chicago, Chicago, Illinois, United States of America.
- University of Chicago Research Bangladesh, Dhaka, Bangladesh.
- Institute for Population and Precision Health (IPPH), Biological Sciences Division, University of Chicago, Chicago, Illinois, United States of America.
- Department of Environmental Health Sciences, Columbia University, New York, New York, United States of America.
ORCID-Profile: Lizeth I Tamayo, Tetiana Davydiuk, Brandon L Pierce
Förderung
- NIEHS NIH HHS
- NIDDK NIH HHS
- National Institute of Environmental Health Sciences
- National Institute of Diabetes and Digestive and Kidney Diseases
Zitieren
APA
Tamayo, L. I., Tong, L., Davydiuk, T., Vander Griend, D., Haque, S. E., Islam, T., Jasmine, F., Kibriya, M. G., Graziano, J., Chen, L., Le, X. C., Ahsan, H., Gamble, M. V., & Pierce, B. L. (2025). Genetic variation in the FMO and GSTO gene clusters impacts arsenic metabolism in humans. PLOS Genetics. https://doi.org/10.1371/journal.pgen.1011826
Vancouver
Tamayo LI, Tong L, Davydiuk T, Vander Griend D, Haque SE, Islam T, et al. Genetic variation in the FMO and GSTO gene clusters impacts arsenic metabolism in humans. PLOS Genetics. 2025. doi:10.1371/journal.pgen.1011826
BibTeX
@article{Tamayo2025,
author = {Tamayo, Lizeth I and Tong, Lin and Davydiuk, Tetiana and Vander Griend, Donald and Haque, Syed Emdadul and Islam, Tariqul and Jasmine, Farzana and Kibriya, Muhammad G and Graziano, Joseph and Chen, Lin and Le, X Chris and Ahsan, Habibul and Gamble, Mary V and Pierce, Brandon L},
title = {Genetic variation in the FMO and GSTO gene clusters impacts arsenic metabolism in humans},
journal = {PLOS Genetics},
year = {2025},
doi = {10.1371/journal.pgen.1011826}
}
EUVIMED